KR20020093966A - 항균제로서의 크로메닐메틸 피리미딘디아민 - Google Patents

항균제로서의 크로메닐메틸 피리미딘디아민 Download PDF

Info

Publication number
KR20020093966A
KR20020093966A KR1020027014451A KR20027014451A KR20020093966A KR 20020093966 A KR20020093966 A KR 20020093966A KR 1020027014451 A KR1020027014451 A KR 1020027014451A KR 20027014451 A KR20027014451 A KR 20027014451A KR 20020093966 A KR20020093966 A KR 20020093966A
Authority
KR
South Korea
Prior art keywords
chromen
dimethyl
ylmethyl
methoxy
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020027014451A
Other languages
English (en)
Korean (ko)
Inventor
모르페터
필리저필리쁘
Original Assignee
바실리어 파마슈티카 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바실리어 파마슈티카 아게 filed Critical 바실리어 파마슈티카 아게
Publication of KR20020093966A publication Critical patent/KR20020093966A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
KR1020027014451A 2000-04-27 2001-04-20 항균제로서의 크로메닐메틸 피리미딘디아민 Ceased KR20020093966A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00108945.7 2000-04-27
EP00108945 2000-04-27
PCT/EP2001/004541 WO2001083476A1 (en) 2000-04-27 2001-04-20 Chromenylmethyl pyrimidinediamines as antibacterial agents

Publications (1)

Publication Number Publication Date
KR20020093966A true KR20020093966A (ko) 2002-12-16

Family

ID=8168565

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027014451A Ceased KR20020093966A (ko) 2000-04-27 2001-04-20 항균제로서의 크로메닐메틸 피리미딘디아민

Country Status (14)

Country Link
US (1) US6818649B2 (cg-RX-API-DMAC7.html)
EP (1) EP1278742B1 (cg-RX-API-DMAC7.html)
JP (1) JP4033676B2 (cg-RX-API-DMAC7.html)
KR (1) KR20020093966A (cg-RX-API-DMAC7.html)
CN (1) CN1249057C (cg-RX-API-DMAC7.html)
AT (1) ATE284882T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001252269A1 (cg-RX-API-DMAC7.html)
BR (1) BR0110255A (cg-RX-API-DMAC7.html)
CA (1) CA2405614A1 (cg-RX-API-DMAC7.html)
DE (1) DE60107832T2 (cg-RX-API-DMAC7.html)
ES (1) ES2232614T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA02010518A (cg-RX-API-DMAC7.html)
WO (1) WO2001083476A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200208271B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243173B (en) 1999-11-17 2005-11-11 Akzo Nobel Nv Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
KR20140015122A (ko) 2003-10-01 2014-02-06 아돌로 코포레이션 스피로시클릭 헤테로시클릭 유도체 및 이의 사용 방법
US7449458B2 (en) * 2005-01-19 2008-11-11 Rigel Pharmaceuticals, Inc. Prodrugs of 2,4-pyrimidinediamine compounds and their uses
US7598261B2 (en) * 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
EP1770089A1 (en) * 2005-10-03 2007-04-04 Institut Pasteur Pyranodibenzofuran derivatives with antifungal and antibacterial activity
US7855194B2 (en) 2006-03-27 2010-12-21 Hoffmann-La Roche Inc. Pyrimidine, quinazoline, pteridine and triazine derivatives
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
CN109134493A (zh) * 2018-09-19 2019-01-04 浙江师范大学 一种具有抗菌活性的2-氧代色烯并噻吩衍生物及其合成方法和应用
CN109988156B (zh) * 2019-03-12 2021-12-28 广东中科药物研究有限公司 一种氨基嘧啶化合物
CN112824412B (zh) * 2019-11-21 2022-09-16 中国科学院大连化学物理研究所 手性1′H-螺[吲哚啉-3,4′-吡喃并[2,3-c]吡唑]-2-酮类化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2238521C (en) * 1995-12-04 2005-08-16 F. Hoffmann-La Roche Ag Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial

Also Published As

Publication number Publication date
ZA200208271B (en) 2004-01-26
EP1278742B1 (en) 2004-12-15
CN1507445A (zh) 2004-06-23
ATE284882T1 (de) 2005-01-15
AU2001252269A1 (en) 2001-11-12
CN1249057C (zh) 2006-04-05
ES2232614T3 (es) 2005-06-01
US6818649B2 (en) 2004-11-16
MXPA02010518A (es) 2003-03-10
DE60107832T2 (de) 2005-06-16
CA2405614A1 (en) 2001-11-08
EP1278742A1 (en) 2003-01-29
DE60107832D1 (en) 2005-01-20
WO2001083476A1 (en) 2001-11-08
JP2004509839A (ja) 2004-04-02
US20030144246A1 (en) 2003-07-31
BR0110255A (pt) 2003-01-07
JP4033676B2 (ja) 2008-01-16

Similar Documents

Publication Publication Date Title
CA2953132C (en) Heteroaryl compounds useful as inhibitors of sumo activating enzyme
KR101166749B1 (ko) 열쇼크 단백질 저해제로서의 이소옥사졸 화합물
JP3117721B2 (ja) 新規なベンジルピリミジン類
EP2635587B1 (en) 6-arylamino pyridone carboxamide as mek inhibitors
ES2949357T3 (es) Inhibidores de 3-fosfoglicerato deshidrogenasa y usos de los mismos
CZ2002534A3 (cs) Inhibitory protein-kináz, farmaceutické prostředky, které je obsahují, a jejich pouľití
JP3545416B2 (ja) フペルジンa誘導体、その製造およびその使用
KR20130135826A (ko) Aids를 치료하기 위한 나프트-2-일아세트산 유도체
KR20120089648A (ko) 결핵 억제제로서의 피리미딘 화합물
TW201514150A (zh) 組蛋白去乙醯酶抑制劑及組成物,暨其使用之方法
ES2233461T3 (es) 5-bencil-2,4-diaminopirimidinas sustituidas.
US6818649B2 (en) Chromenylmethyl pyrimidinediamines as antibacterial agents
AU2021203261B1 (en) Novel dioxoloisoquinolinone derivatives and use thereof
TWI890929B (zh) 作為Wee-1抑制劑的嘧啶化合物
CN111848678A (zh) 含磷类噻吩并嘧啶衍生物
WO2022171126A1 (zh) 作为Wee-1抑制剂的稠环化合物
WO2024212024A1 (en) Novel substituted pyrrole compounds, compositions comprising the substituted pyrrole compound, and methods of use thereof
JP4048054B2 (ja) 抗菌活性を有するピリミジニルメチルインドール誘導体
US4650800A (en) Substituted pyrimidin-2-ones, the salts thereof, pharmaceutical compositions containing them and a method therefor
TW200410970A (en) Heteroaryl-ethanolamine derivatives as antiviral agents
GB2080301A (en) Substituted Pyrimidin-2-ones, the Salts thereof, Processes for their Preparation and Pharmaceutical Compositions Containing them
CN120098001A (zh) 作为细胞周期蛋白依赖性激酶抑制剂的噻吩类化合物及其制备方法和医药用途
AU2006203676A1 (en) Inhibitors of c-JUN N-Terminal Kinases (JNK) and Other Protein Kinases

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

Patent event date: 20021026

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20021026

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20041109

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20050225

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20041109

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I